PPT-CAUTION CONCERNING FORWARD-LOOKING STATEMENTS

This presentation contains forwardlooking information within the meaning of Canadian Securities legislation Generally forwardlooking statements can be identified by the use of forwardlooking terminology such as scheduled anticipates expects or does not expect is expected scheduled targeted or believes or variations of such words and phrases or state that certain actions events or results may could would might or will be taken occur or be achieved Forwardlooking statements contained herein include without limitation statements relating to mineral reserve estimates mineral resource estimates realization of mineral reserve and resource estimates capital and operating costs estimates the timing and amount of future production costs of production success of mining operations the ranking of the project in terms of cash cost and production permitting economic return estimates power and storage facilities life of mine social community and environmental impacts rare metal markets and sales prices offtake agreements and purchasers for the Companys products environmental assessment and permitting securing sufficient financing on acceptable terms opportunities for short and long term optimization of the Project and continued positive discussions and relationships with local communities and stakeholders Forwardlooking statements are based on assumptions management believes to be reasonable at the time such statements are made There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements Accordingly readers should not place undue reliance on forwardlooking statements Although Matamec has attempted to identify important factors that could cause actual results to differ materially from those contained in forwardlooking statements there may be other factors that cause results not to be as anticipated estimated or intended Factors that may cause actual results to differ materially from expected results described in forwardlooking statements include but are not limited to . Forward looking statements may include in particular statements about future events future financial performance plans strategies expectations prospects competitive environment regulation and supply and demand BASF has based these forward looking st 8m ROCHDALE BURNLEY ROSSENDALE 465 471 479 431 437 408 449 409 445 454 411 434 474 419 Dove Scout Callis Bridge Blackshaw Head Gorple Gate The Long Causeway Brown Wardle Hill Reddyshore Scout Rake End Top of Leach Kilnshaw Lane A664 A671 B6377 A680 B Forward looking statements by their nature involve a number of risks and uncertainties that could cause actual results to differ materially from market expectations These risks and uncertainties include but are not limited to our ability to manage g No 14425J Miscellaneous Income Copy A For Internal Revenue Service Center Department of the Treasury Internal Revenue Service File with Form 1096 OMB No 15450115 For Privacy Act and Paperwork Reduction Act Notice see the 2015 General Instructions f brPage 1br Disclosure Statement CAUTION brPage 2br CAUTION brPage 3br CAUTION brPage 4br brPage 1br 20 14 Residential Energy Credits CAUTION CAUTION brPage 2br CAUTION CAUTION CAUTION CAUTION brPage 3br TIP TIP brPage 4br CAUTION CAUTION brPage 5br CAUTION TI Objectives of Lab Caution Sign1. MeetRegulatory Requirements 2. Inform Emergency Responders3. Inform UW Service Staff4. Inform Visitors 5. Provide Consistent Look Regulatory Requirements for Sign LOOKING INFORMATION. This presentation contains forward-looking statements and forward-looking information within the meaning of applicable securities laws, and are subject to risks and uncertainties that could cause actual results to differ. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by Cervus, including expectations and assumptions concerning the results of its due diligence review of the businesses proposed to be acquired by Cervus and the ability to the various approvals required. Additional detail about the material factors and/or assumptions employed to arrive at forward-looking information, as well as the material risk factors that may affect actual results, are contained in the MD&A section of our most recent quarterly filing which is available on the SEDAR website at www.sedar.com. Although Cervus believes that the expectations and assumptions on which such forward-looking statements and information are reasonable, undue reliance should not be placed on the forward looking statements and information as Cervus can give no assurance that they will prove to be correct. By its nature, such forward-looking information is subject to various risks and uncertainties, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date hereof, and to not use such forward-looking information for anything other than its intended purpose. Cervus undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law. OTHER INGREDIENTS.97.5%TOTAL SPECIMEN LABEL PRECAUTIONARY STATEMENTS CAUTION CLEARY CHEMICAL CORPORATION GROUP 19 Prohibited for Any Food or Feed Use IT IS A VIOLATION OF FEDERAL LAW TO USE THIS PRO - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this overview that are not statements of historical fact are forwar CORPORATE PRESENTATION. Pharmaceuticals. Q4 2017. This presentation contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein or which are otherwise made by or on behalf of the Company that are not statements of historical facts may be deemed forward‑looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “to,” “plan,” “expect,” “believe,” “anticipate,” “intend,” “could,” “should,” “would,” “estimate,” or “continue,” or the negative or other variations thereof or comparable terminology are intended to identify forward‑looking statements. Shareholders are cautioned that all forward‑looking statements involve risk and uncertainties which may cause results to differ materially from those set forth in the statements. Such risks and uncertainties include, but are not limited to the following: the success of research and development activities and the speed with which regulatory authorizations and product launches may be achieved; government regulation generally; competitive developments; the ability to successfully market products domestically and internationally; difficulties or delays in manufacturing or issues relating to manufacturing capacity; commercial obstacles to the successful introduction of brand products generally; legal defense costs, insurance expenses, settlement costs, and the risk of an adverse decision or settlement relating to product liability, patent protection, governmental investigations, and other legal proceedings; the Company’s ability to acquire and protect patents and other intellectual property both domestically and internationally; the absence of certainty regarding the receipt of required regulatory approval or the timing or terms of such approvals; any changes in business, political and economic conditions; business interruption due to hurricanes or other events outside of the Company’s control.. Certain statements in this presentation constitute “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Any statements that refer to expectations or other characterizations of future events, circumstances or results are forward-looking statements. Such forward-looking statements include projections. Such projections were not prepared in accordance with public guidelines of the American Institute of Certified Public Accountants regarding projections and forecasts, nor have such projections been audited, examined or otherwise reviewed by independent auditors of Wyndham Worldwide Corporation (“WYN”).. Dupuytren’s. Contracture; the expansion of the market for XIAFLEX for the treatment of . Peyronie’s. Disease and . Dupuytren’s. Contracture through future growth initiatives; the timing of Endo’s BLA submission and potential FDA approval in connection with and the potential commercial launch of XIAFLEX for the treatment of cellulite; whether treating uterine fibroids with XIAFLEX will achieve the advantages over major surgery identified by the Company and the timing of future clinical trials and the publication of results of clinical trials; Endo’s interest in currently unlicensed indications; whether XIAFLEX will be the only FDA approved nonsurgical therapy for adhesive capsulitis; the projected receipt of payments from Endo and sublicense income payments based on Endo’s partnerships; and the strength of the Company’s IP portfolio..